Generic Peptides Somatropin 100 to 200 IU HGH Kits for Sale
Out of stock
Injection · 10 mg · vial
Generic Peptides PT-141 is bremelanotide, a melanocortin receptor agonist that prefers MC4 and acts centrally on desire and arousal, supplied as a 10 mg lyophilised research vial.
Each vial is GMP-manufactured and HPLC-verified with a Certificate of Analysis on file, and reconstitutes with bacteriostatic water. PT-141 for sale with U.S. domestic and international shipping.
Generic Peptides PT-141 is bremelanotide, a melanocortin receptor agonist with a preference for MC4 that works centrally on sexual desire and arousal instead of on blood flow. Its approved form is the prescription injection Vyleesi, licensed for hypoactive sexual desire disorder in premenopausal women, so this compound has a clinical record that most research peptides on the line do not. The vial here is a 10 mg lyophilised research material, not the licensed product.
Bremelanotide activates MC4 receptors in the central nervous system, which is why studies measure desire and arousal rather than vascular response, a clear difference from the PDE5 route. The approved injection is given subcutaneously at 1.75 mg and has an elimination half-life of about 2.7 hours, with a range of 1.9 to 4.0 hours in the labelling. Nausea is the most common effect reported, at about 40 per cent against 8 per cent on placebo.
A 10 mg vial with 2 ml of bacteriostatic water gives 5 mg per ml, and with 1 ml it gives 10 mg per ml, so volumes for a given amount halve. Add the water down the vial wall, do not shake, and store the solution at 2-8 C without freezing. The other melanocortin entry on this line is Melanotan II, which shares the receptor family but has no approved form, while the older PT-141 listing covers the same peptide from another brand line.
Every batch is produced under GMP conditions and checked by independent HPLC, with the Certificate of Analysis held for the batch. Reported effects follow the clinical programme: nausea in about 40 per cent of participants, flushing, and a transient rise in blood pressure, which is why the approved product carries a cardiovascular warning. No separate ban by name for bremelanotide was found in the WADA prohibited list, and no decision data are published, so the sporting status should be treated as unclear rather than open.
For laboratory research only. Consult a healthcare professional before use.
| Trade Name | PT-141 (bremelanotide) |
| Generic Name | Bremelanotide |
| Manufacturer | Generic Peptides |
| Dosage | 10 mg per lyophilised vial |
| Package | 1 vial of powder for reconstitution |
| Drug Class | Research peptide, melanocortin MC4 receptor agonist |
| Administration | Reconstitute with bacteriostatic water |
| Reference Half-Life | About 2.7 hours, range 1.9 to 4.0 hours |
| Shipping | International and U.S. domestic options |
Consult a healthcare professional before any cycle. Where a stack suppresses natural testosterone, PCT is required. Doses are common community protocols.
Before you ask
It is bremelanotide, a melanocortin receptor agonist supplied as a 10 mg lyophilised research vial. The compound prefers the MC4 receptor and acts centrally on desire and arousal rather than on blood flow, and its approved form is the prescription injection Vyleesi. This vial is a research material and not the licensed product, which is prescribed only by a doctor.
It activates MC4 receptors in the central nervous system, so the measurable outcome is desire and arousal rather than vascular response. That is a clear difference from the PDE5 route used by erectile dysfunction drugs. The approved injection is given subcutaneously at 1.75 mg, and its elimination half-life is about 2.7 hours, with a range of 1.9 to 4.0 hours in the labelling.
About 2.7 hours, with a range of 1.9 to 4.0 hours in the approved labelling after subcutaneous administration. That figure comes from clinical work on the licensed injection and not from this research vial. Published detection windows for the compound do not exist in the project fact base, so no claim about testing windows can be made.
Two millilitres of bacteriostatic water give 5 mg per ml, and 1 ml gives 10 mg per ml, so the same drawn volume holds half as much in the more dilute solution. Add the solvent down the vial wall and do not shake, then store the solution at 2-8 C without freezing and follow the use window printed on the vial.
Nausea is the most common effect, reported by about 40 per cent of participants against 8 per cent on placebo in the clinical programme, with flushing also frequent. The approved product carries a warning about a transient rise in blood pressure, which is why clinical use is supervised. Nothing on this page is medical advice, and the prescription product belongs with a doctor.
No separate ban by name for bremelanotide was found in the WADA prohibited list, and the project fact base records no decision data on the compound. That absence of a listing does not mean the product is cleared for sport, and athletes should check the current list with their federation before using anything, given how often entries change.
Yes. The 10 mg vial is listed on this page with international and U.S. domestic shipping options, and the price charged matches the option you select. Orders are dispatched after payment confirmation. The product is sold strictly for laboratory research and is not a licensed medicine anywhere, unlike the prescription injection that contains the same peptide.
Be the first to share your experience with Generic Peptides PT-141 10 mg Bremelanotide Research Vial
Log in to write a reviewComplete the cycle
Out of stock
Out of stock
Out of stock